Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells

作者：Tokunaga Masayuki; Baron Byron; Kitagawa Takao; Tokuda Kazuhiro; Kuramitsu Yasuhiro^*

来源：Anticancer Research, 2015, 35(11): 6063-6067.

• HSF1
• HMGB1
• HSP27
• AHCC
• pancreatic cancer
• gemcitabine

Background: Active hexose-correlated compound (AHCC) is an extract of a basidiomycete mushroom that enhances the therapeutic effects and reduces the side-effects of chemotherapy. Our previous studies demonstrated that heat-shock protein 27 (HSP27) was involved in gemcitabine-resistance of pancreatic cancer cells and it was downregulated by AHCC-treatment. However, how AHCC downregulated HSP27 is unknown. In the present study, we focused on two transcription factors reported to induce HSP27, heat shock factor 1 (HSF1) and high-mobility group box 1 (HMGB1) and investigated the effect of AHCC on their expression. Materials and Methods: KLM1-R cells were treated with AHCC and the protein expression of HSF1 and HMGB1 were analyzed by western blotting. Results: The protein expression of HSF1 in KLM1-R was down-regulated by AHCC treatment. On the other hand, the protein expression of HMGB1 was not reduced in KLM1-R cells after AHCC treatment. Conclusion: The possibility that AHCC down-regulated HSP27 through down-regulation of the HSF1, was herein shown.

• 出版日期2015-11